-Determine what the most promising biofluid-based biomarkers for neurodegenerative dementias are

-Compare the diagnostic and prognostic performance of the most promising biofluid-based biomarkers for neurodegenerative dementias

-Describe what is needed for clinical implementation

Session date: 
04/06/2026 - 4:00pm to 5:00pm CDT
Location: 
In-person and Virtually
1685 Highland Ave
MFCB-Room 1220
United States
See map: Google Maps
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report